Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?

BACKGROUND: To date, no drugs have been approved for gambling disorder. Numerous publications have described the value of opioid antagonists. Indeed, the mesocorticolimbic dopaminergic pathway has been suggested as the underlying cause of reward-seeking behaviour, and it is modulated by the opioid s...

Descripción completa

Detalles Bibliográficos
Autores principales: Victorri-Vigneau, Caroline, Spiers, Andrew, Caillet, Pascal, Bruneau, Mélanie, Challet-Bouju, Gaëlle, Grall-Bronnec, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295935/
https://www.ncbi.nlm.nih.gov/pubmed/28721822
http://dx.doi.org/10.2174/1570159X15666170718144058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295935/
https://www.ncbi.nlm.nih.gov/pubmed/28721822
http://dx.doi.org/10.2174/1570159X15666170718144058

Ejemplares similares